Stereotaxis (STXS) Posts Quarterly Earnings Results

Stereotaxis (OTCMKTS:STXS) released its quarterly earnings results on Tuesday, August 7th. The medical equipment provider reported ($0.02) EPS for the quarter, Bloomberg Earnings reports. The firm had revenue of $7.55 million for the quarter. Stereotaxis had a negative net margin of 20.13% and a negative return on equity of 8.59%.

Shares of OTCMKTS:STXS traded up $0.11 during midday trading on Friday, hitting $0.97. 223,539 shares of the stock traded hands, compared to its average volume of 20,418. Stereotaxis has a one year low of $0.51 and a one year high of $1.10.

Stereotaxis Company Profile

Stereotaxis, Inc designs, manufactures, and markets robotic systems and instruments for the treatment of abnormal heart rhythms in the United States and internationally. Its products include Niobe ES robotic system that enables physicians to complete interventional procedures by providing image guided delivery of catheters and guide wires through the blood vessels and chambers of the heart to treatment sites; and Vdrive system, which offers navigation and stability for the diagnostic and therapeutic devices designed to enhance interventional procedures.

Recommended Story: Moving Average – How it Helps Investors in Stock Selection

Earnings History for Stereotaxis (OTCMKTS:STXS)

Receive News & Ratings for Stereotaxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stereotaxis and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply